Providence Medical Technology Gets US FDA Clearance of CORUS Navigation Access System

Providence Medical Technology Gets US FDA Clearance of CORUS Navigation Access System

By, Admin 18 June 2024

Providence Medical Technology gets US FDA clearance of CORUS navigation access system for use with Medtronic's StealthStation system in posterior spinal fusion procedures

Overview

Providence Medical Technology, Inc, a global innovator in solutions for spinal surgery, announced that the US Food and Drug Administration (FDA) has cleared the use of the CORUS navigation access system for use with the CORUS spinal system during spinal surgery. The CORUS navigation access system is specifically designed for use with Medtronic's StealthStation system for posterior spinal fusion procedures. This US FDA clearance strengthens Providence Medical Technology's portfolio and underscores its commitment to advancing spinal surgery for high-risk spinal fusion patients.

CORUS Navigation Access System: Assistance 

The CORUS navigation access system assists spine surgeons in locating and preparing facet joints in open and minimally invasive spinal surgery procedures and is designed for use with the Medtronic StealthStation system.

Benefits of CORUS Navigation Access System

  • The CORUS navigation access system is intended to assist surgeons in locating, accessing, and preparing facet joints for posterior fusion procedures. 
  • It enables surgeons to utilize surgical navigation to perform procedures with its novel CORUS spinal system. 
  • Surgical guidance and navigation have become increasingly utilized in spinal surgical procedures, particularly for less invasive surgical techniques.
  • The potential benefits of utilizing the CORUS navigation access system to perform a navigated CORUS fusion include: Enhanced accuracy and precision with surgical instruments and spinal implants, e.g., CAVUX FFS-LXp; Improved visualization of the facet joints and other anatomical structures during procedures; Reduced risk of complications and shorter operative time.

From Barrow Neurological Institute

Bryan Lee, MD, a neurosurgeon at Barrow Neurological Institute, commented, ""The newly released CORUS navigation system offers simplicity and accuracy for placement of CAVUX FFS-LX implants and provides the surgeon with a truly minimally invasive approach for posterior fusion, with a wide array of indications, including advanced disc degeneration and adjacent segment disease.""

From CEO: Providence Medical Technology

  • "We are thrilled to integrate our CORUS spinal system with the leading surgical navigation platform and allow for incredible precision and safety in posterior fusion surgeries," said Jeff Smith, CEO of Providence Medical Technology. 
  • "This clearance signifies another leap forward in our mission to improve clinical outcomes for high-risk patients and prevent surgical failures of the spine."

Spinal Surgery

  • The CORUS navigation access system for use with the CORUS spinal system is intended to be used during spinal surgery to assist the surgeon in locating and preparing facet joints in either open or minimally invasive procedures. 
  • The CORUS navigation access system is specifically designed for use with the Medtronic StealthStation system, which is indicated for any medical condition in which the use of stereotactic surgery may be appropriate, and where reference to a rigid anatomical structure, such as a long bone, or vertebra can be identified relative to a CT or MR-based model, fluoroscopy images, or digitized landmarks of the anatomy.

Indication

CORUS spinal system-X is a set of instruments indicated to be used to perform posterior cervical fusion in patients with cervical degenerative disc disease.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!